Host immunity limits iron availability to pathogenic bacteria, but whether immunity limits pathogenic bacteria from accessing host heme, the major source of iron in the body, remains unclear. Using Citrobacter rodentium (a mouse enteric pathogen) and Escherichia coli (a major cause of sepsis in humans) as models, we find that interleukin-22 (IL-22), a cytokine best known for its ability to promote epithelial barrier function, also suppresses the systemic growth of bacteria by limiting iron availability to the pathogen. To understand the mechanistic basis of IL-22-dependent iron retention in the host, using an unbiased proteomic approach, we have identified that IL-22 induces the production of the plasma hemoglobin scavenger haptoglobin and the heme scavenger hemopexin. Moreover, the antimicrobial effect of IL-22 depends on the induction of hemopexin expression, whereas haptoglobin was dispensable. Impaired pathogen clearance in infected Il22−/− mice was restored by hemopexin administration, and hemopexin-deficient mice had increased pathogen loads after infection. These studies reveal a previously unrecognized host defense mechanism regulated by IL-22 that relies on the induction of hemopexin to limit heme availability to bacteria, leading to suppression of bacterial growth during systemic infections.
INTRODUCTION
Iron is an essential nutrient for nearly all microorganisms, including pathogenic bacteria (1) . In mammals, most of the iron is found inside erythrocytes, contained in the prosthetic heme groups of hemoglobin (2) . Given their strict requirement for iron, pathogenic bacteria evolved strategies to trigger hemolysis as a means to extract iron from hemo globin (1) . Bacterial pathogens have several mechanisms to overcome the limited availability of iron in the circulation or at local niches. These include production of siderophores that bind iron at extremely high af finity, heme acquisition systems, and mechanism for the uptake of transferrin and lactoferrinbound iron (1) . Host immunity encompasses several mechanisms that limit host iron availability to pathogenic bac teria (3) (4) (5) (6) , a defense strategy known as nutritional immunity (7) . This host defense strategy involves a reduction of circulating or local iron by inhibition of cellular iron export and the induction of cellular iron import by host cells via hepcidindependent and hepcidinindependent mech anisms (3) (4) (5) (6) . Whether nutritional immunity limits pathogenic bacteria from accessing host heme, the major source of iron, remains unclear.
Interleukin22 (IL22) is an important cytokine that promotes early host defense, epithelial barrier function, and tissue repair at mucosal surfaces (8, 9) . In response to bacterial infection, IL22 is produced by several immune cells, leading to the induction of innate antimicrobial molecules that are thought to promote host defense and intestinal bar rier protection against pathogens (10) . The protective function of IL22 was revealed by the observation that Il22 −/− mice are highly suscep tible to the attaching and effacing (A/E) mouse pathogen Citrobacter rodentium. In the absence of IL22, there was marked intestinal dam age and bacterial translocation in orally infected mice (8, 9) . IL22 signals through a heterodimeric receptor complex comprised a ubiq uitously expressed IL10R2 (IL10 receptor 2) subunit and an epithelial specific IL22RA1 subunit (11, 12) . Because of the highly restricted ex pression of the IL22RA1 subunit, IL22 stimulates epithelial cells on certain organs, such as the liver and kidney, as well as epithelial barriers, including the skin and the intestine (13) . Using C. rodentium and Escherichia coli infection models, we report that IL22 induces a systemic protective response that is mediated by hemopexin (HPX), a plasma heme scavenger produced in the liver, which limits the availability of heme iron to the microbes and suppresses bacterial systemic growth.
RESULTS

IL-22 promotes pathogen clearance and host survival after systemic infection with C. rodentium
Consistent with earlier studies (8, 9) , Il22 −/− mice succumbed early to oral infection with C. rodentium, which was associated with increased pathogen load in blood, liver, and spleen ( fig. S1 ). Systemic C. rodentium infection induced rapid production of IL22 in plasma (Fig. 1A) . To determine whether IL22 controls pathogen growth systemically, we infected wildtype (WT) and Il22 −/− mice with C. rodentium intravenously and monitored them for survival and pathogen load in the blood. Sur prisingly, >90% of the Il22 −/− mice succumbed to intra venous infec tion compared with ~20% of the WT mice (Fig. 1B) . Mortality of infected Il22 −/− mice was associated with impaired pathogen clearance, resulting in increased pathogen load in blood (Fig. 1C) . Pathogeninduced le thality in Il22 −/− mice required live bacteria because the animals did not succumb when injected intravenously with heatkilled C. rodentium ( fig.  S2 ). Although antibody production is critical to control C. rodentium oral infection (14, 15) , the production of pathogenspecific immuno globulin M (IgM) and IgG was not impaired in Il22 −/− mice, as com pared with WT mice (fig. S3 ). To ascertain the role of IL22 in controlling pathogen growth, we pretreated Il22 −/− mice with recombinant IL22 before intravenous C. rodentium infection and assessed the pathogen loads in the blood. Administration of IL22 reduced pathogen load (Fig. 1D ). In our mouse colony, ~90% of the bacteria present in the liver of orally infected Il22 −/− mice were C. rodentium, although a few com mensals, particularly Lactobacillus spp., were also identified ( fig. S1G ).
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To determine whether C. rodentium infection could induce mortality in the absence of commensals, we pretreated WT germfree (GF) mice with an IL22-neutralizing antibody and infected the mice with the pathogen via the oral route. Neutralization of IL22 reduced the surviv al of GF mice after oral C. rodentium infection (Fig. 1E) , which was associated with increased pathogen loads in blood, liver, and spleen ( Fig. 1, F to H) . Collectively, these results indicate that IL22 limits the systemic expansion of C. rodentium and promotes host survival.
IL-22 regulates plasma HPX and haptoglobin after pathogen infection
To understand further the mechanism by which IL22 promotes sys temic pathogen clearance, we set to identify, by liquid chromatogra phy coupled with tandem mass spectrometry (LCMS/MS) analysis, plasma proteins regulated by IL22 before and after infection of WT and Il22 −/− mice with C. rodentium intravenously. Consistent with previous studies (16, 17) , several pro teins including serum amyloid A1, serum amyloid A2, interαtrypsin inhibitor heavy chain, adiponec tin, Creactive protein, α2macroglobulin, and com plement factors were reduced in the plasma of infected Il22 −/− mice compared with infected WT mice (Fig. 2) . In addition, the induction of the plasma extracellular heme scavenger HPX (18) and the hemoglobin scavenger haptoglobin (HP) (19) in response to C. rodentium in fection was severely impaired in Il22 −/− mice compared with WT mice (Fig. 2) . This was associated with the accumulation of extracellular hemoglobin α and βglobin chains in the plasma of infected Il22 −/− mice compared with WT mice (Fig. 2) . Intraperitoneal ad ministration of IL22 restored the induction of HP and HPX expression in the plasma of Il22 −/− mice compared with Il22 −/− mice treated with control protein (Fig. 2) .
Hemolysis driven by bacterial virulence factors promotes pathogen growth in Il22 −/− mice Accumulation of extracellular hemoglobin α and βglobin chains in the plasma of Il22 −/− mice suggested that IL22 deficiency is associated with augmented he molysis after systemic C. rodentium infection and/or with impaired disposal of extracellular hemoglobin from plasma. To verify that hemoglobin proteins are regu lated by IL22, we assessed the amounts of αglobin in the plasma of uninfected and infected WT and Il22 −/− mice by immunoblotting. The analysis confirmed that the amounts of αglobin were increased in the plasma of Il22 −/− mice in response to intravenous or oral infec tion with C. rodentium (Fig. 3, A and B) . Because scav enging of extracellular hemoglobin dimers by HP prevents the release of the prosthetic heme groups of hemoglobin (20, 21) , we asked whether induction of HP by IL22 was associated with inhibition of heme accumulation in plasma. Il22 −/− mice infected via the intravenous or oral route accumulated heme in plasma, whereas infected WT mice did not (Fig. 3C ). Consistent with a role of hemoglobin release from lysed erythro cytes in promoting pathogen growth, intravenous administration of lysed erythrocytes to C. rodentiuminfected WT mice increased their pathogen loads in the blood (Fig. 3D) . The filament protein EspA as well as EspB and EspD are required for the assembly of the translocon of the entero cyte effacement (LEE)-encoded type III secretion system (T3SS) and promote the formation of EspB/EspD pores that mediate eryth rocyte lysis in vitro (22) . To assess whether C. rodentium translocators induce erythrocyte lysis, we incubated mouse erythrocytes in vitro with WT and C. rodentium mutants deficient in EspA, EspB, and Ler, the global regulator of the LEE that is critical for pathogen viru lence (23) . The WT bacterium, but not the EspA, EspB, and Ler mutants, induced erythrocyte lysis (Fig. 3E) . To determine whether EspB is important for hemolysis associated with systemic growth and lethality of C. rodentium in vivo, we infected Il22 −/− mice with WT or the EspB mutant and monitored the pathogen loads in blood as well as mouse survival. Deficiency of EspB was associated with reduced pathogen loads and the absence of lethality when compared with the WT bacterium that caused 100% mortality in Il22 −/− mice (Fig. 3 , F and G). Ler ex pression was detected in the blood of mice after intravenous infection with C. rodentium ( fig. S4A ). Furthermore, the reduced ability of the EspB mutant to grow systemically was not associated with reduced expression of ler in infected WT or Il22 −/− mice ( fig. S4B ). In con trast to the EspB mutant, the pathogen load of a C. rodentium mutant deficient in EspH, a T3SS effector that regulates phagocytosis (24) , was comparable with that of the WT bacterium in infected Il22−/− mice ( fig. S5 ). The Ler mutant that regulates the expression of LEEencoded proteins, including EspB, also exhibited reduced pathogen loads and failed to cause mortality in Il22 −/− mice when compared with the WT bacterium ( fig. S6 ). Growth of the EspB mutant was enhanced in vivo by intravenous administration of lysed erythrocytes (Fig. 3H ). Further more, EspB and Ler promoted heme accumulation in plasma after intravenous infection of Il22 −/− mice with C. rodentium ( Fig. 3I and  fig. S6 ). In contrast, the amounts of iron and the unsaturated ironbinding capacity in plasma before and after infection with C. rodentium were comparable in WT and Il22 −/− mice ( fig. S7 ). Thus, IL22 regulates heme, but not free iron, accumulation in the plasma after systemic C. rodentium infection. These results indicate that he molysis driven by LEEencoded EspB translocator and ensuing release of heme in plasma promotes C. rodentium growth in vivo.
IL-22-dependent induction of HPX inhibits heme-mediated bacterial growth
Analysis of plasma proteins by LCMS/MS revealed that HPX and HP are positively regulated by IL22 in response to systemic C. rodentium infection (Fig. 2) . Immunoblotting analysis of plasma proteins con firmed that IL22 is required for induction of HPX and HP in response to intravenous and oral C. rodentium infection (Fig. 4 , A to C). The IL 22R is expressed on epithelial cells including hepatocytes, the major site of HPX and HP production (25, 26) . Consistently, intraperitoneal ad ministration of IL22 induced HPX and HP mRNA in the liver ( fig. S8 ).
To determine whether C. rodentium infection induces antibacterial activity in plasma, we monitored C. rodentium colonies in vitro after incubation with plasma from uninfected and infected mice. Plasma from infected WT mice inhibited C. rodentium colony formation com pared with plasma of uninfected WT mice (Fig. 4D) . Plasma from in fected Il22 −/− mice failed to limit colony formation compared with the plasma of infected WT mice (Fig. 4D) . Consistently, intravenous administration of recombinant IL22 to Il22 −/− mice restored the plas ma antibacterial activity (Fig. 4E) . To identify the mechanism under lying this antibacterial activity in plasma, we fractionated plasma proteins from IL22-treated mice by column chromatography and assessed the pathogeninhibitory activity in the fractions by agar plat ing assay. Immunoblotting analysis showed that the presence of the heme scavenger HPX, but not the hemoglobin scavenger HP, correlated with the ability of the plasma fractions to suppress C. rodentium colony formation (Fig. 4F) . To determine whether heme promotes C. rodentium growth, we incubated the pathogen in vitro with and with out synthetic heme (i.e., hemin) in the pres ence of increasing con centrations of HPX. In the absence of HPX, hemin promoted robust C. rodentium colony formation in vitro (Fig. 4G) , whereas addi tion of HPX, at a concentration range found in mouse plasma, that is, ~500 to 1000 μg/ml (27) , inhibited hemindriven pathogen growth in a dosedependent manner (Fig. 4G) . Hemoglobin also promoted robust C. rodentium colony formation in vitro, which was inhibited by HPX in a dosedependent manner (Fig. 4H) , whereas HP did not ( fig. S9 ). Furthermore, exogenous HPX largely restored the antibacte rial activity of the plasma isolated from infected Il22−/− mice in vitro (Fig. 4I) . Collectively, these results suggest that once released from extracellular hemoglobin, heme promotes C. rodentium growth, a pathogenic effect countered via a mechanism mediated by the IL22-dependent induction of the plasma heme scavenger HPX.
IL-22 limits heme-mediated E. coli growth via HPX
E. coli, a Gramnegative bacterium that normally inhabits the intes tine, is a major cause of bacteremia and sepsis in humans (28, 29) . As it was observed with C. rodentium, hemin promoted robust colony for mation of an E. coli strain isolated from the mouse intestine that was inhibited by HPX in vitro (Fig. 5A) . Furthermore, administration of recombinant IL22 to Il22 −/− mice restored the ability of plasma to suppress E. coli colony formation in vitro (Fig. 5B) , which was strictly dependent on the expression of endogenous HPX (Fig. 5C ). Further more, Il22 −/− and Hpx −/− mice were more susceptible and had more bac terial loads than WT mice after intravenous infection with E. coli (Fig. 5 , D to G). These results indicate that E. coli colony formation is promoted by heme, which is inhibited by IL22-mediated induction of HPX. 
IL-22 requires HPX, but not HP, to suppress pathogen growth in vitro and in vivo
We next assessed the requirement for HPX and HP in IL22-mediated suppression of bacterial growth. The ability of plasma from IL22-treated WT mice to suppress C. rodentium colony formation was com parable with that of plasma from Hp −/− mice treated with IL22 (Fig. 6A) . In contrast, the plasma of Hpx −/− and Hpx −/− Hp −/− mice treated with IL22 was impaired in suppressing C. rodentium growth, which was comparable with the plasma of untreated WT mice (Fig. 6 , B and C). To confirm that IL22 suppresses pathogen growth in vivo via a mechanism involving heme neutralization by HPX, we intraperi toneally administered IL22 to WT, Hpx (Fig. 6G) . Furthermore, administration of HPX reduced the pathogen load in Il22 −/− mice compared with mocktreated mice after intravenous (Fig. 6H ) and oral infection (Fig. 6, I and J). Together, these results indicate that IL22 limits the growth of C. rodentium via HPX in vivo.
DISCUSSION
IL22 has been primarily linked to the regulation of host defense, cellular proliferation, and tissue repair at intestinal barriers (10) . In the current studies, we provide evidence for a role of IL22 in pro tecting the host against the enteric pathogen C. rodentium and the commensal E. coli by mediating the production of HPX in plasma. Although produced by immune cells in response to microbial stimuli, IL22 stimulates its heterodimeric IL22RA1/IL10R2 on epithelial cells, including hepatocytes that are known to produce large amounts of HPX (18) . Induction of HPX in response to systemic infections was so far thought to protect the infected host from hemeinduced cell toxicity, inflammation, and multiorgan dysfunction (30) , without interfering with the host pathogen load and, as such, conferring dis ease tolerance to systemic bacterial infections (30, 31) . This protec tive effect of HPX and its removal by macrophages and parenchymal cells have also been extended to several other pathologies associated with varying degrees of hemolysis (25) . Our work demonstrates that IL22-induced HPX also confers resistance to systemic bacterial infec tions by limiting the heme availability to bacteria. Pathogens have several mechanisms to overcome ironlimiting defenses induced by the host, including siderophores, hemophores, and heme/hemoprotein receptors (1). Thus, pathogens capable of colonizing ironpoor niches are likely to be less susceptible to IL22-mediated HPX induction. C. rodentium and E. coli appear to rely on strategies to acquire iron from heme when they colonize the plasma and systemic organs. C. rodentium and E. coli produce enterobactin, a siderophore, and its receptor FepA to acquire iron and may express functional heme uptake systems (32, 33) . Our results suggest that C. rodentium promotes hemolysis and heme acquisition through pore formation via T3SS mediated factors and specifically EspB/EspD. EspH, a T3SS effector that regulates phagocytosis, was dispensable for pathogen growth in Il22 −/− mice. These findings suggest that the T3SS promotes bacterial growth by inducing hemolysis. However, there may be additional factors, including compromised ability to block phagocytosis, that might contribute to the impaired ability of T3SS mutants to infect the mice. Further work is needed to understand how C. rodentium and E. coli acquire iron from heme in vivo.
Our studies indicate that pathogenic bacteria like A/E pathogens take advantage of virulence strategies such as expression of Lerdependent factors normally used to colonize the intestinal epithelium to survive in alternative niches such as the blood in the event of causing bacteremia. Administration of IL22-binding protein (IL22-BP), a natural antag onist of IL22 signaling, has been reported to enhance the systemic clearance of commensal bacteria in a model of polymicrobial sepsis (34) . Further work is needed to determine whether the protective func tion of IL22-BP is mediated through the induction of HPX and/or another mechanism. Our results suggest that strategies to scavenge heme in plasma, such as that afforded by the administration of IL22, HPX, or other approaches, may be beneficial in the treatment of sys temic bacterial infections.
MATERIALS AND METHODS
Study design
The aim of this study was to elucidate and characterize the mechanism by which IL22 mediates systemic protection against bacterial infection using the C. rodentium and E. coli models in mice. The experimental design involved in vivo and in vitro ex periments, including protein identifica tion by LCMS/MS, chromatographic fractionation of plasma proteins, immu noblotting, histological analysis, reverse transcription polymerase chain reaction analysis, and bacterial colony enumeration. The animal experiments were not random ized. The investigators were not blinded to the allocation during experiments and analyses unless otherwise indicated. Ex perimental replication is indicated in the figure legends.
Animals
Six to 8weekold WT C57BL6 mice were bred in our animal facility. C. rodentium infection Kanamycinresistant WT C. rodentium strain DBS120 (pCRP1::Tn5) was a gift of D. Schauer, Massachusetts Institute of Technology. The isogenic C. rodentium Δler mutant strain has been described (37) . C. rodentium strains with nonpolar deletion mutants of espA, espB, and espH have been described (23) . For inoc ulations, bacteria were grown overnight in LuriaBertani (LB) broth supplemented with kanamycin (50 μg/ml) with shaking at 37°C. Mice were infected by oral gavage with 0.2 ml of phosphatebuffered saline (PBS) containing about 1 × 10 9 colonyforming units (CFU) of C. rodentium, or by intravenous injection with 0.2 ml of PBS con taining about 5 × 10 7 CFU of C. rodentium. The investigators were not blinded to allocation during experiments. To mimic the con tinuous source of bacteremia observed in Il22 −/− mice orally infected with the pathogen, we infected mice with 5 × 10 7 CFU of C. rodentium intravenously daily for 9 to 10 days. To assess the role of HPX in C. rodentium clearance in vivo, we orally infected Il22 −/− mice with the pathogen (1 × 10 9 CFU) and treated them intravenously with purified HPX (Athens Research and Technology; 2 mg per mouse) or saline on days 3 to 6 after infection. For systemic infections, HPX (2 mg per mouse) or saline (sham) was injected intravenously on three con secutive days before infection or control (sham) into Il22 −/− mice, and then the mice were infected with 5 × 10 7 CFU of C. rodentium intravenously. To determine pathogen loads in the feces, we collected fecal pellets from individual mice, homogenized them in cold PBS, and plated them at serial dilutions onto MacConkey agar plates contain ing kanamycin (50 μg/ml), and we determined the number of CFU after overnight incubation at 37°C. To determine bacterial number in the blood, liver, and spleen, we sacrificed mice at various time points after infection, plated blood or tissue samples onto MacConkey agar plates containing kanamycin (50 μg/ml), and determined the number of CFU after overnight incubation at 37°C.
IL-22 neutralization and administration
To deplete endogenous IL22 in mice, we injected anti-IL22 (150 μg per mouse per dose; 8E11; Genentech) or the equivalent amount of mouse isotypematched control antibody (to ragweed; 10D9.1E11.1F12; Genentech) to the mice three times a week. To treat mice with IL22, we intravenously injected them with Fc-IL22 (50 μg per dose; PRO312045; Genentech) or the equivalent amount of mouse isotypematched control antibody (to ragweed; 10D9.1E11.1F12; Genentech) daily for 3 days and 6 hours after from final injection.
E. coli infection E. coli strain NI1076 was isolated from the mouse intestine mice, as described (17) . For infections, bacteria were grown overnight in LB broth with shaking at 37°C. Mice were infected by intravenous injection with 0.2 ml of PBS containing about 2 × 10 8 CFU of E. coli.
Bacterial growth assays C. rodentium or E. coli (1 × 10 5 CFU/ml) were incu bated in Dulbecco's modified Eagle's medium in the presence of Apotransferrin (500 μg/ml) (Athens Re search and Technology) to chelate free iron. To as sess bacterial growth, we added hemin (2.5 μg/ml; Sigma) or hemoglobin (25 μg/ml; Sigma) to the culture medium in the presence and absence of dif ferent concentrations of HPX (Athens Research and Technology) or HP (Athens Research and Technology).
Statistical analysis
Statistical significance was calculated as indicated in the figure legends using GraphPad Prism 6 software. Logrank test was used to assess mouse survival. Nonparametric MannWhitney test was used for pair comparisons, and Dunn's test was used for multiple comparisons. Dif ferences were considered significant when P values were less than 0.05.
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